No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Sutent (sunitinib) is an oncology drug used to treat certain types of cancer, including gastrointestinal stromal tumors (GIST), advanced renal cell carcinoma (RCC), and pancreatic neuroendocrine tumors (PNET). It is a small molecule tyrosine kinase inhibitor (TKI) that works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. Sutent is typically administered orally, and is available in both capsule and tablet form.
Sutent is a widely used drug in the oncology market, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in combination with other drugs to treat more advanced forms of cancer.
The Sutent market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, Novartis, Merck, and AstraZeneca. Show Less Read more
